The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is prevalent worldwide with complex etiology. Skin barrier defects and abnormal immune activation are crucial in the occurrence and development of AD. In the classic model of the skin barrier, lipids are essential for the formation and maintenance of this barrier as a "mortar" component. However, abnormally activated immune responses promote the lipid barrier deficiency through the secretion of various types of immune mediators directly or indirectly. In this review, we first introduce the skin lipid barrier (SLB) under both normal and abnormal conditions, highlighting the contributions of lipids derived from keratinocytes and sebaceous glands (SGs). Subsequently, the relationships between the immune mediators of Th1, Th2, Th17, Th22, and other types (adipokines, prostaglandins, leukotrienes) and SLB are elaborated in turn. Finally, the therapies for restoring SLB to treat AD are summarized, with a focus on the restoration effect of dupilumab on SLB. We hope that this review will offer a comprehensive perspective for understanding the pathogenesis of lipid metabolism disorders and SLB deficiency caused by immune mediators in AD. It also aims to provide guidance for further research on targeting inflammatory mediators to restore SLB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These features are not only diagnostically useful but also reflect disease-specific immune mechanisms that increasingly inform therapeutic targeting across inflammatory dermatoses [1,2,3,4,5].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [4]
In the citing paper
“Beyond barrier dysfunction, extracellular matrix components actively influence immune signaling.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [4]
In the citing paper
“In subacute lesions, spongiosis persists but is associated with increasing acanthosis and parakeratosis.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [4]
In the citing paper
“Chronic lesions are characterized by irregular epidermal hyperplasia, compact hyperkeratosis, variable parakeratosis, and only mild residual spongiosis [3,4].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [4]
In the citing paper
“Acute lesions are dominated by spongiosis, which is usually the most prominent epidermal alteration and may be accompanied by exocytosis of lymphocytes.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [4]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
Langan, S. M., Irvine, A. D., & Weidinger, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31286-1 · Cited by 1,852
New insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,421
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,073
Imokawa, G., Abe, A., Jin, K., Higaki, Y., Kawashima, M., & Hidano, A. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12470233 · Cited by 1,041
Gittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981
Research works printed but not linked: 1
- Haftek M (2014) ‘Memory’ of the stratum corneum: exploration of the epidermis’ past. Br J Dermatol 171(Suppl):36–39
Cited by
Dinić, M., Gonzalez, T., Hernandez, M., Radojević, D., Fernandez, L., Golić, N., & Pastar, I. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02494-4 · Cited by 19
Prados‐Carmona, Á., Husein‐ElAhmed, H., Navarro‐Triviño, F. J., & Ruíz‐Villaverde, R. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09075-w · Cited by 12
Lu, W., Cao, J., Lv, Y. L., Li, M., Tang, Y. H., & Feng, Y. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03244-y · Cited by 8
“The SC structure is composed of corneocytes enveloped by a tough protein shell and lipids such as ceramides, cholesterol, and fatty acids filling the intercellular spaces[28].”
Wang, J., Zhang, Y., Yuan, S., Zhang, M., Zhang, X., Chen, J., Dou, H., Cheng, H., & Ding, X. (2026) · Nano Research · doi:10.26599/nr.2026.94908421 · Cited by 5
Tinca, A. C., Cozac-Szoke, A. R., & Cotoi, O. S. (2026) · Dermatopathology · doi:10.3390/dermatopathology13020022 · Cited by 1
“In atopic dermatitis, alterations in epidermal lipids and barrier proteins create a permissive environment for microbial colonization, allergen penetration, and sustained immune activation [3,4].”
Influential
Metadata
- Authors
- You, H., & Liang, Y.
- Affiliations
- Second Xiangya Hospital of Central South University (CN)
- Corresponding author
- Liang, Yunsheng
- ORCID
- Liang, Yunsheng
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2025-05-14
- Volume
- 68
- Issue
- 1
- Pages
- 49-49
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W4410347711
- Cited by
- 17
- References
- 239
- Citations by year
- 2026: 12 · 2025: 5
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- atopic dermatitis, immune mediators, Th1/Th2 balance, Th17 cells, Th22 cells, adipokines, prostaglandins, leukotrienes, dupilumab, skin barrier dysfunction
- MeSH terms
- Animals, Dermatitis, Atopic, Disease Susceptibility, Humans, Sebaceous Glands, Skin, Keratinocytes, Cytokines, Inflammation Mediators, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier. https://app.cochat.ai/papers/10.1007/s12016-025-09057-y
- The paper
- You, H., & Liang, Y. (2025). Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-025-09057-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.